Isolation and characterization of human lung cancer antigens by serological screening with autologous antibodies

Cancer Letters

Volumn 301, Issue 1, 2011, Pages 57-62

  Hanafusa, Tadashi ^a   Mohamed, Ali Eldib Ali ^b   Kitaoka, Kenta ^c   Ohue, Yoshihiro ^d   Nakayama, Eiichi ^e   Ono, Toshiro ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Alexandria University Faculty Of Science   (Egypt)

^c HYOGO PREFECTURAL AWAJI HOSPITAL   (Japan)

^d KAWASAKI MEDICAL SCHOOL   (Japan)

^e KAWASAKI UNIVERSITY OF MEDICAL WELFARE   (Japan)

Author keywords

Lung adenocarcinoma; MYL6B; NUP107; SEREX; Tumor antigen

Indexed keywords

AUTOANTIBODY; CHROMOSOME 9 OPEN READING FRAME 23 PROTEIN; CHROMOSOME 9 OPEN READING FRAME 58 PROTEIN; COMPLEMENTARY DNA; CYTOPLASM PROTEIN; CYTOSPIN A; DEBRIN LIKE TRANSCRIPT VARIANT 2 PROTEIN; HEAT SHOCK PROTEIN 70; ISYI SPLICING FACTOR HOMOLOG; MESSENGER RNA; NUCLEAR PROTEIN; NUCLEOPORIN 107; PDZ PROTEIN; PROTEIN SWAP 70; PROTEIN ZO2; RIBOSOMAL PROTEIN S15A; SCATTER FACTOR RECEPTOR; SHORT COILED COIL PROTEIN; TUMOR ANTIGEN; UBIQUITIN CONJUGATING ENZYME E21; UNCLASSIFIED DRUG; UTROPIN; W TYPE ZINC FNGER 2 PROTEIN;

ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE; GENE EXPRESSION; HSPA4 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG PARENCHYMA; MET GENE; MOLECULAR CLONING; MYL6B GENE; NUP107 GENE; PRIORITY JOURNAL; SCOC GENE; SCREENING; SEQUENCE ANALYSIS; SEROLOGY;

ADENOCARCINOMA; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; GENE LIBRARY; HUMANS; LUNG NEOPLASMS;

EID: 78650540341     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.10.024     Document Type: Article

References (32)

1. Alberg A.J., Samet J.M. Epidemiology of lung cancer. Chest 2003, 123:21S-49S.
2. Bröker L.E., Giaccone G. The role of new agents in the treatment of non-small cell lung cancer. Eur. J. Cancer 2002, 38:2347-2361.
3. Sahin U., Türeci O., Schmitt H., Cochlovius B., Johannes T., Schmits R., Stenner F., Luo G., Schobert I., Pfreundschuh M. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA 1995, 92:11810-11813.
4. Chen Y.T., Scanlan M.J., Obata Y., Old L.J. Identification of human tumor antigens by serological expression cloning. Principles and Practice of Biologic Therapy of Cancer 2000, 557-570. Lippincott Williams & Wilkins, Philadelphia. S.A. Rosenberg (Ed.).
5. Y.T. Chen, Identification of Human Tumor Antigens by Serological Expression Cloning: An Online Review on SEREX, Cancer. Immun. [updated 2004 March 10; cited 2004 Apr 1], 2004.
6. Chen Y.T., Scanlan M.J., Sahin U., Türeci O., Güre A.O., Tsang S., Williamson B., Stockert E., Pfreundschuh M., Old L.J. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA 1997, 94:1914-1918.
7. Türeci O., Sahin U., Zwick C., Koslowski M., Seitz G., Pfreundschuh M. Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proc. Natl. Acad. Sci. USA 1998, 95:5211-5216.
8. Scanlan M.J., Chen Y.T., Williamson B., Güre A.O., Stockert E., Gordan J.D., Türeci O., Sahin U., Pfreundschuh M., Old L.J. Characterization of human colon cancer antigens recognized by autologous antibodies. Int. J. Cancer 1998, 76:652-658.
9. Brass N., Rácz A., Bauer C., Heckel D., Sybrecht G., Meese E. Role of amplified genes in the production of autoantibodies. Blood 1999, 93:2158-2166.
10. Türeci O., Sahin U., Vollmar E., Siemer S., Göttert E., Seitz G., Parkkila A.K., Shah G.N., Grubb J.H., Pfreundschuh M., Sly W.S. Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc. Natl. Acad. Sci. USA 1998, 95:7608-7613.
11. Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H., Jongeneel V., Güre A.O., Jäger D., Jäger E., Knuth A., Chen Y.T., Old L.J. Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int. J. Cancer 1999, 83:456-464.
12. Jäger D., Stockert E., Scanlan M.J., Güre A.O., Jäger E., Knuth A., Old L.J., Chen Y.T. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene. Cancer. Res. 1999, 59:6197-6204.
13. Türeci O., Sahin U., Pfreundschuh M. Serological analysis of human tumor antigens: molecular definition and implications. Mol. Med. Today 1997, 3:342-349.
14. Güre A.O., Altorki N.K., Stockert E., Scanlan M.J., Old L.J., Chen Y.T. Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3. Cancer Res. 1998, 58:1034-1041.
15. Güre A.O., Stockert E., Scanlan M.J., Keresztes R.S., Jäger D., Altorki N.K., Old L.J., Chen Y.T. Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. Proc. Natl. Acad. Sci. USA 2000, 97:4198-4203.
16. Diesinger I., Bauer C., Brass N., Schaefers H.J., Comtesse N., Sybrecht G., Meese E. Toward a more complete recognition of immunoreactive antigens in squamous cell lung carcinoma. Int. J. Cancer 2002, 102:372-378.
17. Park S., Lim Y., Lee D., Cho B., Bang Y.J., Sung S., Kim H.Y., Kim D.K., Lee Y.S., Song Y., Jeoung D.I. Identification and characterization of a novel cancer/testis antigen gene CAGE-1. Biochim. Biophys. Acta 2003, 1625:173-182.
18. Ali Eldib A.M., Ono T., Shimono M., Kaneko M., Nakagawa K., Tanaka R., Noguchi Y., Nakayama E. Immunoscreening of a cDNA library from a lung cancer cell line using autologous patient serum: Identification of XAGE-1b as a dominant antigen and its immunogenicity in lung adenocarcinoma. Int. J. Cancer 2004, 108:558-563.
19. Nakagawa K., Noguchi Y., Uenaka A., Sato S., Okumura H., Tanaka M., Shimono M., Ali Eldib A.M., Ono T., Ohara N., Yoshino T., Yamashita K., Tsunoda T., Aoe M., Shimizu N., Nakayama E. XAGE-1 expression in non-small cell lung cancer and antibody response in patients. Clin. Cancer Res. 2005, 11:5496-5503.
20. Domae S., Nakamura Y., Nakamura Y., Uenaka A., Wada H., Nakata M., Oka M., Kishimoto K., Tsukamoto G., Yoshihama Y., Matsuoka J., Gochi A., Kohno S., Saika T., Sasaki A., Nakayama E., Ono T. Identification of CCDC62-2 as a novel cancer/testis antigen and its immunogenicity. Int. J. Cancer 2009, 124:2347-2352.
21. Walther T.C., Alves A., Pickersgill H., Loïodice I., Hetzer M., Galy V., Hülsmann B.B., Köcher T., Wilm M., Allen T., Mattaj I.W., Doye V. The conserved Nup107-160 complex is critical for nuclear pore complex assembly. Cell 2003, 113:195-206.
22. Loïodice I., Alves A., Rabut G., Van Overbeek M., Ellenberg J., Sibarita J.B., Doye V. The entire Nup107-160 complex, including three new members, is targeted as one entity to kinetochores in mitosis. Mol. Biol. Cell. 2004, 15:3333-3344.
23. Doucet C.M., Talamas J.A., Hetzer M.W. Cell cycle-dependent differences in nuclear pore complex assembly in metazoa. Cell 2010, 141:1030-1041.
24. Emterling A., Skoglund J., Arbman G., Schneider J., Evertsson S., Carstensen J., Zhang H., Sun X.F. Clinicopathological significance of Nup88 expression in patients with colorectal cancer. Oncology 2003, 64:361-369.
25. Zhang H., Schneider J., Rosdahl I. Expression of p16, p27, p53, p73 and Nup88 proteins in matched primary and metastatic melanoma cells. Int. J. Oncol. 2002, 21:43-48.
26. Agudo D., Gómez-Esquer F., Martínez-Arribas F., Núñez-Villar M.J., Pollán M., Schneider J. Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer. Int. J. Cancer 2004, 109:717-720.
27. Borrow J., Shearman A.M., Stanton V.P., Becher R., Collins T., Williams A.J., Dubé I., Katz F., Kwong Y.L., Morris C., Ohyashiki K., Toyama K., Rowley J., Housman D.E. The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nat. Genet. 1996, 12:159-167.
28. Nakamura T., Yamazaki Y., Hatano Y., Miura I. NUP98 is fused to PMX1 homeobox gene in human acute myelogenous leukemia with chromosome translocation t(1;11)(q23;p15). Blood 1999, 94:741-747.
29. Ahuja H.G., Felix C.A., Aplan P.D. The t(11;20)(p15;q11) chromosomal translocation associated with therapy-related myelodysplastic syndrome results in an NUP98-TOP1 fusion. Blood 1999, 94:3258-3261.
30. Taketani T., Taki T., Shibuya N., Kikuchi A., Hanada R., Hayashi Y. Novel NUP98-HOXC11 fusion gene resulted from a chromosomal break within exon 1 of HOXC11 in acute myeloid leukemia with t(11;12)(p15;q13). Cancer Res. 2002, 62:4571-4574.
31. Lahortiga I., Vizmanos J.L., Agirre X., Vázquez I., Cigudosa J.C., Larrayoz M.J., Sala F., Gorosquieta A., Perez-Equiza K., Calasanz M.J., Odero M.D. NUP98 is fused to adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t(10;11)(q25;p15). Cancer Res. 2003, 63:3079-3083.
32. Shimono M., Uenaka A., Noguchi Y., Sato S., Okumura H., Nakagawa K., Kiura K., Tanimoto M., Nakayama E. Identification of DR9-restricted XAGE antigen on lung adenocarcinoma recognized by autologous CD4 T-cells. Int. J. Oncol. 2007, 30:835-840.